Delivery Order SPE2DR25D9158-SPE2DR26FBSDP
- Not listed
- The Defense Logistics Agency issued a firm fixed-price delivery order valued at $13,516.56 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for yellow fever vaccine (YF-VAX) products. The delivery order, awarded on November 18, 2025, with an ultimate completion date of December 16, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This...
- The Defense Logistics Agency issued a delivery order valued at $1,113.52 to DMS Pharmaceutical Group Inc. for YF-VAX (yellow fever vaccine) dose vials on December 4, 2025. This firm fixed-price delivery order, with an ultimate completion date of December 26, 2025, represents a routine pharmaceutical procurement under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency. The award carries no set-aside designation, indicating competitive procurement...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,670.28 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in one-dose vial format. The delivery order, issued on December 4, 2025, with an ultimate completion date of December 26, 2025, was awarded without a set-aside designation, demonstrating DMS Pharmaceutical Group's competitive capability in unrestricted...
- The Defense Logistics Agency awarded a $1,113.42 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for YF-VAX (yellow fever vaccine) in single-dose vials on October 20, 2025. The delivery order, with an ultimate completion date of November 10, 2025, carries no set-aside designation, allowing the woman-owned small business to compete directly against other qualified vendors. DMS Pharmaceutical Group, headquartered in Park Ridge, Illinois, is the sole awardee with no identified...
- The Defense Logistics Agency awarded a $1,113.52 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in single-dose vials. The delivery order, issued on December 4, 2025, with an ultimate completion date of December 26, 2025, carries no set-aside designation, indicating the award was made through unrestricted federal procurement. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $2,227.04 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for Yellow Fever vaccine (YF-VAX) one-dose vials. The award was issued on December 9, 2025, with an ultimate completion date of December 31, 2025, under firm fixed-price terms with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite...
- The Defense Logistics Agency awarded a $1,113.52 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) vials. The delivery order, issued on December 1, 2025, with an ultimate completion date of December 22, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This award is issued under DMS...
- The Defense Logistics Agency awarded a delivery order valued at $1,113.54 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in single-dose vials. The delivery order, issued on December 6, 2025, with an ultimate completion date of December 29, 2025, utilizes firm fixed-price pricing with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,227.04 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in single-dose vials. This firm fixed-price delivery order, awarded on November 4, 2025, with an ultimate completion date of November 26, 2025, represents a routine pharmaceutical supply requirement supporting Department of Defense medical operations. The award carries no...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $2,783.80 to DMS Pharmaceutical Group Inc. for YF-VAX (yellow fever vaccine) in one-dose vial quantities. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement. The delivery order, issued on November 5, 2025, with an...
- SPE2DR25D9158Indefinite Delivery Contract
- SPE2DR25D9158-SPE2DR26FBSDPDelivery Order
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,113.52 to DMS Pharmaceutical Group Inc. for Yellow Fever vaccine (YF-VAX) vials on December 9, 2025, with an ultimate completion date of December 31, 2025. This delivery order was issued without a set-aside designation, allowing DMS Pharmaceutical Group to compete directly against all eligible contractors. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, serves as a critical supplier within the federal pharmaceutical supply chain, specializing in distributing comprehensive pharmaceutical products and medical consumables to the Department of Defense and other federal agencies. This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR. The parent IDC, awarded on November 13, 2025, carries a ceiling value of $499,999,999 and extends through December 31, 2036, comprising a 30-month base period with three 30-month option periods. The PPV-G GEN V represents part of a broader $30.3 billion acquisition strategy designed to provide the Department of Defense with reliable access to pharmaceutical products and medical consumables to support military healthcare facilities worldwide. DMS Pharmaceutical Group's established performance on numerous prior delivery orders demonstrates its capability to fulfill the specialized pharmaceutical requirements of the federal military medical system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 12/8/25 |